Lundbeck
HLUN-B.CO
#2310
Rank
A$11.52 B
Marketcap
A$11.61
Share price
-0.73%
Change (1 day)
6.29%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2026 (TTM): A$1.12

According to Lundbeck's latest financial reports the company's current EPS (TTM) is A$1.09. In 2025 the company made an earnings per share (EPS) of A$0.72 an increase over its 2024 EPS that were of A$0.63.

EPS history for Lundbeck from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$1.1255.2%
2025A$0.7214.5%
2024A$0.6329.29%
2023A$0.4923.09%
2022A$0.4037.26%
2021A$0.29-84.61%
2020A$1.88-24.61%
2019A$2.49-42.06%
2018A$4.3040.7%
2017A$3.06146.26%
2016A$1.24-120.48%
2015A-$6.063231.32%
2014A-$0.18-115.78%
2013A$1.15-23.36%
2012A$1.50-48.01%
2011A$2.89-9.68%
2010A$3.2013.72%
2009A$2.8224.32%
2008A$2.27-6.05%
2007A$2.4181.77%
2006A$1.33-16.76%
2005A$1.59-17.58%
2004A$1.93